Shanghai Yahon Pharmaceutical Technology

Shanghai Yahon Pharmaceutical Technology is a research-driven pharmaceutical company and a subsidiary of Aben Chem (Yaben Chemical). The company focuses on the development of innovative small molecule drugs and high-end generic pharmaceutical intermediates, operating as both an independent developer and a CDMO partner. Its primary therapeutic focus areas include anti-infectives (notably COVID-19 treatments), oncology, and central nervous system disorders. Yahon leverages its parent company's chemical manufacturing expertise to bridge the gap between laboratory discovery and large-scale production of complex active pharmaceutical ingredients.